Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-26-056233
Filing Date
2026-05-06
Accepted
2026-05-06 16:02:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2613429d2_424b5.htm 424B5 414906
2 GRAPHIC tm2613429d2_424b5img001.jpg GRAPHIC 7936
3 GRAPHIC tm2613429d2_424b5img003.jpg GRAPHIC 2750
4 GRAPHIC tm2613429d2_424b5img002.jpg GRAPHIC 8107
  Complete submission text file 0001104659-26-056233.txt   442398
Mailing Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-291570 | Film No.: 26948186
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)